Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Barter · SciRah

Researcher profile · Semantic Scholar

P. Barter

Share profile

P. Barter — researcher profile on SciRah

h-index: 90
Works: 507
Citations: 51K

Most-cited papers

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
R. Ross, I. Neeland, S. Yamashita, I. Shai +13 more
2020Nature Reviews Endocrinology1,732 citations Open access
Semantic Scholar
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.
I. Neeland, R. Ross, J. Despres, Y. Matsuzawa +13 more
2019The Lancet Diabetes and Endocrinology1,335 citations Open access
Semantic Scholar
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson, H. Brewer, B. Ansell, P. Barter +5 more
2015Nature Reviews Cardiology774 citations Open access
Semantic Scholar
Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease
M. Lincoff, S. Nicholls, J. Riesmeyer, P. Barter +25 more
2017New England Journal of Medicine705 citations Open access
Semantic Scholar
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
S. Nicholls, A. Lincoff, Dianna Bash, C. Ballantyne +13 more
2018Clinical Cardiology162 citations Open access
Semantic Scholar
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
A. Vallejo-Vaz, R. Fayyad, S. Boekholdt, G. Hovingh +5 more
2018Circulation152 citations Open access
Semantic Scholar
Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.
B. Karlson, O. Wiklund, M. Palmer, S. Nicholls +2 more
2016European Heart Journal - Cardiovascular Pharmacotherapy142 citations Open access
Semantic Scholar
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology
R. Rosenson, H. Brewer, P. Barter, J. Björkegren +8 more
2018Nature Reviews Cardiology133 citations
Semantic Scholar
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
J. Fruchart, Raul D. Santos, C. Aguilar-Salinas, M. Aikawa +51 more
2019Cardiovascular Diabetology114 citations Open access
Semantic Scholar
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
K. Ong, A. Januszewski, R. O'Connell, A. Jenkins +8 more
2015Diabetologia101 citations Open access
Semantic Scholar
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia.
B. Karlson, M. Palmer, S. Nicholls, P. Lundman +1 more
2016American Journal of Cardiology99 citations
Semantic Scholar
Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial
G. Schwartz, C. Ballantyne, P. Barter, D. Kallend +8 more
2017JAMA cardiology90 citations Open access
Semantic Scholar
Cholesteryl ester transfer protein and its inhibitors
Sudichhya Shrestha, Ben J. Wu, L. Guiney, P. Barter +1 more
2018Journal of Lipid Research83 citations Open access
Semantic Scholar
Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle
Shudi Tang, F. Tabet, B. Cochran, L. C. Cuesta Torres +3 more
2019Scientific Reports64 citations Open access
Semantic Scholar
HDL cholesterol and ASCVD risk stratification: A debate.
P. Barter, J. Genest
2019Atherosclerosis62 citations
Semantic Scholar
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis
B. Karlson, M. Palmer, S. Nicholls, P. Lundman +1 more
2016European Journal of Preventive Cardiology60 citations
Semantic Scholar
New Era of Lipid-Lowering Drugs
P. Barter, K. Rye
2016Pharmacological Reviews58 citations Open access
Semantic Scholar
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
D. Waters, S. Bangalore, R. Fayyad, D. Demicco +3 more
2017Journal of Clinical Lipidology57 citations Open access
Semantic Scholar
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.
B. Arsenault, F. Petrides, F. Tabet, W. Bao +10 more
2017Journal of Clinical Lipidology56 citations Open access
Semantic Scholar
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East
Mostafa Q Alshamiri, M. Ghanaim, P. Barter, Kuan-Cheng Chang +7 more
2018International Journal of General Medicine48 citations Open access
Semantic Scholar
HDL cholesterol concentration or HDL function: which matters?
P. Barter, K. Rye
2017European Heart Journal48 citations
Semantic Scholar
Dyslipidaemia in the Middle East: Current status and a call for action.
K. Al Rasadi, W. Almahmeed, K. Alhabib, M. Abifadel +7 more
2016Atherosclerosis48 citations Open access
Semantic Scholar
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
R. Puri, C. Ballantyne, R. Hoogeveen, M. Shao +8 more
2017Atherosclerosis47 citations
Semantic Scholar
Apolipoprotein A-I interactions with insulin secretion and production
K. Rye, P. Barter, B. Cochran
2016Current Opinion in Lipidology45 citations
Semantic Scholar
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.
M. Palmer, P. Barter, P. Lundman, S. Nicholls +2 more
2019Clinical Biochemistry44 citations Open access
Semantic Scholar
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial.
Andrew L. Siebel, Si Khiang Trinh, M. Formosa, P. Mundra +18 more
2016Metabolism: Clinical and Experimental43 citations
Semantic Scholar
Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region
Zhen-Vin Lee, E. Llanes, R. Sukmawan, N. Thongtang +2 more
2021Lipids in Health and Disease41 citations Open access
Semantic Scholar
High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males
F. Tabet, L. C. Cuesta Torres, Leung-Ong Kwok, Sudichhya Shrestha +4 more
2016PLoS ONE41 citations Open access
Semantic Scholar
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A. Lincoff, S. Nicholls, J. Riesmeyer, P. Barter +2 more
201740 citations Open access
Semantic Scholar
Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database.
B. Karlson, M. Palmer, S. Nicholls, P. Barter +1 more
2017Atherosclerosis40 citations
Semantic Scholar
Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead—Pro
P. Barter, K. Rye
2016Arteriosclerosis, Thrombosis and Vascular Biology35 citations Open access
Semantic Scholar
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study).
Leung-Ong Kwok, N. Hui, A. Januszewski, N. Kaakoush +8 more
2019Metabolism: Clinical and Experimental34 citations Open access
Semantic Scholar
Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL.
N. Hui, P. Barter, K. Ong, K. Rye
2019Clinical science33 citations Open access
Semantic Scholar
Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice
Rosanna W. S. Chung, Ze-Neng Wang, C. Bursill, Ben J. Wu +2 more
2017PLoS ONE33 citations Open access
Semantic Scholar
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
G. Schwartz, Lawrence A Leiter, C. Ballantyne, P. Barter +11 more
2020Diabetes Care32 citations Open access
Semantic Scholar
In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes
B. Cochran, W. Ryder, A. Parmar, Shudi Tang +9 more
2016Diabetologia32 citations Open access
Semantic Scholar
Variations in time to benefit among clinical trials of cholesterol-lowering drugs.
P. Barter, D. Waters
2018Journal of Clinical Lipidology31 citations
Semantic Scholar
A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo
R. Puranik, S. Bao, A. Bonin, R. Kaur +6 more
2016Cell & Bioscience27 citations Open access
Semantic Scholar
Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease.
B. Tucker, R. McClelland, M. Allison, M. Budoff +4 more
2020Atherosclerosis26 citations Open access
Semantic Scholar
Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats.
Ben J. Wu, Yi-Dan Sun, K. Ong, Yue Li +3 more
2019Arteriosclerosis, Thrombosis and Vascular Biology26 citations Open access
Semantic Scholar
Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis
K. Ong, R. McClelland, M. Allison, J. Kokkinos +3 more
2018Atherosclerosis26 citations Open access
Semantic Scholar
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East.
Nasreen Al Sayed, K. Al Waili, F. Alawadi, Saeed Al-Ghamdi +10 more
2016International Journal of Cardiology26 citations Open access
Semantic Scholar
Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism
B. Cochran, Liming Hou, Anil Paul Chirackal Manavalan, Benjamin M. Moore +15 more
2016Diabetes25 citations Open access
Semantic Scholar
Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition
Ben J. Wu, Yue Li, Leung-Ong Kwok, Yi-Dan Sun +5 more
2017Arteriosclerosis, Thrombosis and Vascular Biology23 citations
Semantic Scholar
The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments
E. Pandžić, I. Gelissen, R. Whan, P. Barter +4 more
2017Scientific Reports23 citations Open access
Semantic Scholar
Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease.
Sébastien A. Choteau, L. C. Cuesta Torres, J. Barraclough, A. Elder +9 more
2018International Journal of Cardiology20 citations
Semantic Scholar
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
B. Karlson, M. Palmer, S. Nicholls, P. Lundman +1 more
2015Atherosclerosis20 citations
Semantic Scholar
Cholesteryl Ester Transfer Protein Inhibition Enhances Endothelial Repair and Improves Endothelial Function in the Rabbit
Ben J. Wu, Sudichhya Shrestha, Ong L. Kwok, D. Johns +3 more
2015Arteriosclerosis, Thrombosis and Vascular Biology19 citations Open access
Semantic Scholar
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study.
K. Ong, R. O'Connell, A. Januszewski, A. Jenkins +11 more
2017Clinical Chemistry16 citations Open access
Semantic Scholar
Evaluation of the impact of statin therapy on the obesity paradox in patients with acute myocardial infarction
K. Won, S. Hur, C. Nam, S. Ann +19 more
2017Medicine16 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Rye×25
Invite
K. Rye — researcher profile on SciRah
S. Nicholls×11
Invite
S. Nicholls — researcher profile on SciRah
Ben J. Wu×8
Invite
Ben J. Wu — researcher profile on SciRah
B. Karlson×7
Invite
B. Karlson — researcher profile on SciRah

×6

Invite

M. Palmer — researcher profile on SciRah

Invite

P. Lundman — researcher profile on SciRah

Sudichhya Shrestha×6

Invite

Sudichhya Shrestha — researcher profile on SciRah

Invite

K. Ong — researcher profile on SciRah

Invite

F. Tabet — researcher profile on SciRah

Invite

B. Cochran — researcher profile on SciRah

B. Arsenault×4

Invite

B. Arsenault — researcher profile on SciRah

C. Ballantyne×4

Invite

C. Ballantyne — researcher profile on SciRah